Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Vera shares skyrocket as kidney disease drug succeeds in late-stage trial
June 2 (Reuters) - Shares of Vera Therapeutics VERA.O soared 82% on Monday, after the company said its experimental drug helped significantly reduce excess levels of harmful proteins in the urine of kidney disease patients in a late-stage study. The drug developer's shares surged to $34.24 in pr...
Reuters
Mon, Jun 2
Kymera rises after positive early-stage results for experimental drug
** Shares of drug developer Kymera Therapeutics KYMR.O rise 39.16% to $41.25 premarket** Company says its experimental oral drug showed robust STAT6 degradation in blood and skin in early-stage trial** The drug, KT-621, targets STAT6 — a signaling protein that plays a key role in immune response ...
Reuters
Mon, Jun 2
Kirkland's Inc
expected to post a loss of 47 cents a share - Earnings Preview
Kirkland's Inc KIRK.OQ KIRK.O is expected to show a fall in quarterly revenue when it reports results on June 4 (estimated) for the period ending April 30 2025The Brentwood Tennessee-based company is expected to report a 6.7% decrease in revenue to $85.6 million from $91.75 million a year ago,...
Reuters
Mon, Jun 2
2 No-Brainer Growth Stocks to Buy in June
Growth investors have had to dig deeper in 2025. With the S&P 500 flat year to date amid President Trump's global trade reset and persistent inflation, the broad-market rally has stalled. But under the surface, a new class of winners is emerging, driven by breakthroughs in artificial intelligence (A...
The Motley Fool
Mon, Jun 2
Is Occidental Petroleum Stock a Buy Now?
The one factor that investors need to understand about the energy sector is that it is volatile. Oil and natural gas prices can, and do, move dramatically and quickly at times. Right now, oil prices are a little soft, and Occidental Petroleum's (NYSE: OXY) shares are down around 35% from their 52-we...
The Motley Fool
Mon, Jun 2
Voyager Technologies - To Offer 11 Million Shares In IPO - SEC Filing
June 2 (Reuters) - Voyager Technologies Inc VOYG.N:VOYAGER TECHNOLOGIES INC - TO OFFER 11 MILLION SHARES IN IPO - SEC FILINGVOYAGER TECHNOLOGIES INC - IPO PRICE RANGE SET AT $26.00 TO $29.00 PER SHARE - SEC FILINGVOYAGER TECHNOLOGIES-DYLAN TAYLOR TO OWN 10.3% OF OUTSTANDING CAPITAL STOCK, CONTROL 63...
Reuters
Mon, Jun 2
Publicis and WPP drop after WSJ report on Meta's automated AI ad system
** Shares of adland's leaders Publicis PUBP.PA and WPP WPP.L drop around 4% each after the Wall Street Journal reported that Meta META.O will unveil a fully automated AI system for ad creation and targeting** Meta's new AI tool, designed to leverage real-time behavioural data from Facebook, ...
Reuters
Mon, Jun 2
GLOBAL MARKETS-Shares and dollar tumble as tariff tensions flare
Europe's STOXX down, S&P futures dented by risk-off mood Dollar down before jobs data, steel levies deadline Oil bounces on relief OPEC did not raise output even furtherECB expected to cut rates, BoC on hold By Wayne Cole and Amanda Cooper SYDNEY/LONDON, June 2 (Reuters) - Stocks and the ...
Reuters
Mon, Jun 2
European insurers' peak valuations are hard to justify, Exane says
** BNP Paribas Exane says the possibly peaked valuations in the European insurance sector can be difficult to justify** European insurers have outperformed the broader market by more than 10% YTD, with price-to-earnings ratios trading close to 10-year highs, the brokerage says** Property and casualt...
Reuters
Mon, Jun 2
BREAKINGVIEWS-Sanofi finds M&A fix for its multiple itches
By Neil Unmack LONDON, June 2 (Reuters Breakingviews) - Sanofi SASY.PA is one European giant that’s still focused on the United States. The $123 billion French drugmaker will pay up to $9.5 billion for Blueprint Medicines BPMC.O, a U.S. group whose key product fights a rare blood disorder which ...
Reuters
Mon, Jun 2
These Unstoppable Ultra-High-Yielding Dividend Stocks Have Increased Their Payments for at Least the Past 49 Straight Quarters
The best dividend stocks strive to increase their payments once a year. Over 150 have managed to do that for the past decade, which is impressive considering all that has transpired in the past 10 years. While many companies aim to give their investors an annual raise, some have a higher standard. T...
The Motley Fool
Mon, Jun 2
Here's Why I Plan to Apply for Social Security at 1 of the Least Popular Claiming Ages
If you've ever looked into when you should claim Social Security, you've probably come across a lot of conflicting information. Nearly a quarter of all seniors sign up at 62 -- the earliest possible claiming age -- but others say that's a bad idea, because doing so shrinks your checks by up to 30% f...
The Motley Fool
Mon, Jun 2
US STOCKS-Wall Street futures slip after Trump's steel tariff threat
Futures down: Dow 0.2%, S&P 500 0.31%, Nasdaq 0.44%Boeing rises on brokerage upgradeBlueprint Medicines gains on Sanofi's buyout offerBy Kanchana Chakravarty and Sukriti Gupta June 2 (Reuters) - U.S. stock index futures dipped on Monday following President Donald Trump's plans to doub...
Reuters
Mon, Jun 2
Red Rock Resorts rises after Mizuho upgrades to 'outperform', hikes PT
** Shares of casino company Red Rock Resorts RRR.O rise 1.2% to $49 in premarket ** Mizuho upgrades stock to "outperform" from "neutral"** Raises price target to $59 from $50; new PT at a premium of 22.7% to stock's last close ** Says it believes RRR could be a beneficiary of...
Reuters
Mon, Jun 2
U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures dipped on Monday after President Donald Trump announced plans to double tariffs on imported steel and aluminum, amplifying concerns about trade- and tariff-related v...
Reuters
Mon, Jun 2
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond will usually allow anyone to earn superior returns. That's not a secret, but it's easy to forget when d...
The Motley Fool
Mon, Jun 2
BioNTech climbs on cancer drug deal with Bristol Myers
** U.S.-listed shares of German vaccine maker BioNTech 22UAy.DE, BNTX.O rise 13.7% to $108.90 premarket** BNTX and Bristol Myers Squibb BMY.N announced global partnership to jointly develop and commercialize an experimental cancer drug, BNT327 ** BMY will pay BioNTech $1.5 billion upfront, up to $2 ...
Reuters
Mon, Jun 2
Street View: EOG Resources' Encino deal on track to boost acreage position
** U.S. energy producer EOG Resources EOG.N said on Friday it will acquire Encino Acquisition Partners for $5.6 billion, including debt, to strengthen its Utica Shale position** Median PT of 31 brokerages covering stock is $139 - data compiled by LSEGANALYSTS REACT POSITIVELY TO EOG'S ENCINO DEA...
Reuters
Mon, Jun 2
LIVE MARKETS-Europe's 'big 5' luxury brands may lose market share again in 2025-MS
STOXX 600 down 0.2%Trade policy uncertainty weighsPolish stocks lead way lowerWall St futures inch lowerWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comEUROPE'S 'BIG 5' LU...
Reuters
Mon, Jun 2
Boeing's Stock Is Crushing the Market in 2025. Can It Continue?
Boeing (NYSE: BA) stock is up 13.6% this year compared to a minimal gain for the S&P 500, primarily due to management's improved performance under relatively new CEO Kelly Ortberg, who was appointed last August and continues to steer the company in a positive direction. The key question is whether t...
The Motley Fool
Mon, Jun 2
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free